Related Experiment Video
Updated: Jul 24, 2025

Refined Murine Model of Idiopathic Pulmonary Fibrosis
Published on: June 17, 2025
FOXO3 regulates Smad3 and Smad7 through SPON1 circular RNA to inhibit idiopathic pulmonary fibrosis
Hailong Li1, Jinhe Li1,2, Yayue Hu1,2
1The State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Key Laboratory of Molecular Drug Research, Nankai University.
Abstract:
Forkhead box protein O3 (FOXO3) has good inhibition ability toward fibroblast activation and extracellular matrix, especially for the treatment of idiopathic pulmonary fibrosis. How FOXO3 regulates pulmonary fibrosis remains unclear. In this study, we reported that FOXO3 had binding sequences with F-spondin 1 (SPON1) promoter, which can activate its transcription and selectively promote the expression of SPON1 circRNA (circSPON1) but not mRNA expression. We further demonstrated that circSPON1 was involved in the extracellular matrix deposition of HFL1. In the cytoplasm, circSPON1 directly interacted with TGF-β1-induced Smad3 and inhibited the activation of fibroblasts by inhibiting nuclear translocation. Moreover, circSPON1 bound to miR-942-5p and miR-520f-3p that interfered with Smad7 mRNA and promoted Smad7 expression. This study revealed the mechanism of FOXO3-regulated circSPON1 in the development of pulmonary fibrosis. Potential therapeutic targets and new insights into the diagnosis and treatment of idiopathic pulmonary fibrosis based on circRNA were also provided.
Insights
Forkhead box protein O3 (FOXO3) regulates pulmonary fibrosis by controlling circSPON1. This circular RNA inhibits fibroblast activation and extracellular matrix deposition, offering new therapeutic targets for idiopathic pulmonary fibrosis.
Area of Science:
- Molecular Biology
- Cell Biology
- Pulmonary Medicine
Background:
- Idiopathic pulmonary fibrosis (IPF) is characterized by excessive fibroblast activation and extracellular matrix deposition.
- Forkhead box protein O3 (FOXO3) shows potential in inhibiting these processes, but its regulatory mechanism in pulmonary fibrosis is not fully understood.
Purpose of the Study:
- To elucidate the mechanism by which FOXO3 regulates pulmonary fibrosis through F-spondin 1 (SPON1) and its derived circular RNA (circSPON1).
- To investigate the role of circSPON1 in fibroblast activation and extracellular matrix deposition in the context of pulmonary fibrosis.
Main Methods:
- Analysis of FOXO3 binding to the SPON1 promoter.
- Assessment of circSPON1 expression and its impact on HFL1 cells.
- Investigation of circSPON1 interaction with Smad3 and its effect on nuclear translocation.
- Study of circSPON1 binding to microRNAs (miR-942-5p and miR-520f-3p) and its influence on Smad7 expression.
Main Results:
- FOXO3 activates SPON1 transcription, selectively promoting circSPON1 expression over mRNA.
- circSPON1 is implicated in extracellular matrix deposition in HFL1 cells.
- cytoplasmic circSPON1 inhibits fibroblast activation by preventing Smad3 nuclear translocation.
- circSPON1 upregulates Smad7 expression by sponging miR-942-5p and miR-520f-3p.
Conclusions:
- This study reveals a novel FOXO3-circSPON1 pathway crucial for regulating pulmonary fibrosis development.
- circSPON1 acts as a key mediator, inhibiting fibroblast activation and extracellular matrix deposition.
- The findings provide potential circRNA-based therapeutic targets and diagnostic insights for idiopathic pulmonary fibrosis.
Related Concept Videos
TGF - β Signaling Pathway
The JAK-STAT Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
Master Transcription Regulators
Experimental RNAi
Regulation of Angiogenesis and Blood Supply

